Nasal nitric oxide and sinonasal disease: A systematic review of published evidence

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 2, 2011, Pages 159-169

  Phillips, P Seamus ^a   Sacks, Raymond ^b   Marcells, George N ^c   Cohen, Noam A ^d   Harvey, Richard J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b ANZAC Research Institute   (Australia)

^c SYDNEY EYE HOSPITAL   (Australia)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Nitric; Oxide; Review; Rhinology; Systematic

Indexed keywords

NITRIC OXIDE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BRONCHODILATATION; CILIARY MOTILITY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; HUMAN; MEASUREMENT; NASAL NITRIC OXIDE MEASUREMENT; NEUROTRANSMISSION; NOSE POLYP; NOSE SURGERY; PARANASAL SINUS DISEASE; PROGNOSIS; RESPIRATORY TRACT EXAMINATION; REVIEW; RHINOSINUSITIS; SYSTEMATIC REVIEW; THERMOREGULATION; UPPER RESPIRATORY TRACT; VASODILATATION; CHEMISTRY; METABOLISM; NOSE DISEASE; NOSE MUCOSA; PARANASAL SINUS;

HUMANS; NASAL MUCOSA; NITRIC OXIDE; NOSE DISEASES; PARANASAL SINUS DISEASES; PARANASAL SINUSES;

EID: 79959610799     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810392667     Document Type: Review

References (57)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376. (Pubitemid 11169009)
2. Ignarro LJ, Buga GM, Byrns RE, Wood KS, Chaudhuri G. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. J Pharmacol Exp Ther. 1988;246:218-226.
3. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526. (Pubitemid 17085822)
4. Belvisi MG, Stretton CD, Yacoub M, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol. 1992;210:221-222.
5. Runer T, Cervin A, Lindberg S, Uddman R. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg. 1998;119:278-287. (Pubitemid 28425614)
6. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001;2:149-156. (Pubitemid 33585926)
7. MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995;81:641-650.
8. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818-2825. (Pubitemid 27278655)
9. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;100:2417-2423. (Pubitemid 27514879)
10. Lundberg JO, Lundberg JM, Settergren G, Alving K, Weitzberg E. Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand. 1995;155:467-468.
11. Krouse JH. The unified airway-conceptual framework. Otolaryngol Clin North Am. 2008;41:257-266, v. (Pubitemid 351324829)
12. Silkoff PE, Chatkin J, Qian W, et al. Nasal nitric oxide: a comparison of measurement techniques. Am J Rhinol. 1999;13:169-178.
13. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912-930.
14. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 1997;10:1683-1693. (Pubitemid 27311092)
15. Struben VM, Wieringa MH, Mantingh CJ, de Jongste JC, Feenstra L. Nasal NO measurement by direct sampling from the nose during breathhold: aspiration flow, nasal resistance and reproducibility. Eur Arch Otorhinolaryngol. 2006;263:723-728. (Pubitemid 44060975)
16. Phillips CR, Giraud GD, Holden WE. Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J Appl Physiol. 1996;80:1865-1871. (Pubitemid 26243760)
17. Giraud GD, Nejadnik B, Kimberly B, Holden WE. Physical characteristics and gas composition of nasal air affect nasal nitric oxide release. Respir Physiol. 1998;114:285-296. (Pubitemid 29050876)
18. Rinder J. Effects of topical nasal decongestants, L-arginine and nitric oxide synthase inhibition, on nasal cavity nitric oxide levels and nasal cavity volume in man. Am J Rhinol. 1996;10:399-408. (Pubitemid 27050807)
19. Lundberg JO, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J. 1994;7:1501-1504. (Pubitemid 24268339)
20. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1:370-373.
21. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol. 1983;46:198-202. (Pubitemid 13045860)
22. Lindberg S, Cervin A, Runer T. Low levels of nasal nitric oxide (NO) correlate to impaired mucociliary function in the upper airways. Acta Otolaryngol (Stockh). 1997;117:728-734. (Pubitemid 27418204)
23. Holden WE, Wilkins JP, Harris M, Milczuk HA, Giraud GD. Temperature conditioning of nasal air: effects of vasoactive agents and involvement of nitric oxide. J Appl Physiol. 1999;87:1260-1265. (Pubitemid 29483106)
24. Silkoff PE, Roth Y, McClean P, Cole P, Chapnik J, Zamel N. Nasal nitric oxide does not control basal nasal patency or acute congestion following allergen challenge in allergic rhinitis. Ann Otol Rhinol Laryngol. 1999;108:368-372. (Pubitemid 29190150)
25. Qian W, Sabo R, Ohm M, Haight JS, Fenton RS. Nasal nitric oxide and the nasal cycle. Laryngoscope. 2001;111:1603-1607. (Pubitemid 32843863)
26. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399-405. (Pubitemid 23042288)
27. Lundberg JO, Settergren G, Gelinder S, Lundberg JM, Alving K, Weitzberg E. Inhalation of nasally derived nitric oxide modulates pulmonary function in humans. Acta Physiol Scand. 1996;158:343-347. (Pubitemid 26426964)
28. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004;114:923-930. (Pubitemid 38625551)
29. Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006;61:717-724. (Pubitemid 43801406)
30. Bommarito L, Guida G, Heffler E, et al. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2008;101:358-362.
31. Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg. 2002;126:481-489. (Pubitemid 41123534)
32. Henriksen AM, Sue-Chu M, Lingaas Holmen T, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J. 1999;13:301-306. (Pubitemid 29086824)
33. Qian W, Chatkin JM, Djupesland PG, et al. Unilateral nasal nitric oxide measurement after nasal surgery. Ann Otol Rhinol Laryngol. 2000;109:952-957.
34. Kirihene RKDRA, Rees G, Wormald P-J. The influence of the size of the maxillary sinus ostium on the nasal and sinus nitric oxide levels. Am J Rhinol. 2002;16:261-264. (Pubitemid 35314856)
35. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol (Stockh). 1997;117:113-117. (Pubitemid 27077016)
36. Boot JD, De Kam ML, Mascelli MA, et al. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy. 2007;62:378-384. (Pubitemid 46398806)
37. Ferguson EA, Eccles R. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant. Acta Otolaryngol (Stockh). 1997;117:614-617. (Pubitemid 27359776)
38. Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L, Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir Med. 1998;92:558-561. (Pubitemid 28162171)
39. Lundberg JO, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child. 1996;75:323-326. (Pubitemid 26354604)
40. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis: clinical and experimental. Allergy. 1997;27:358-362. (Pubitemid 27183357)
41. Arnal JF, Flores P, Rami J, et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J. 1999;13:307-312. (Pubitemid 29086825)
42. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child. 1996;75:319-322. (Pubitemid 26354603)
43. Colantonio D, Brouillette L, Parikh A, Scadding GK. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy. 2002;32:698-701. (Pubitemid 34534014)
44. Kharitonov SA, Rajakulasingam K, O'Connor B, Durham SR, Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol. 1997;99:58-64.
45. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: influence of atopy and hayfever on nNO. Am J Rhinol. 2006;20:425-429. (Pubitemid 44575702)
46. Struben VMD, Sewbalak WV, Wieringa MH, et al. Nasal nitric oxide in cystic fibrosis with and without humming. Eur J Clin Invest. 2007;37:140-174.
47. Thomas SR, Kharitonov SA, Scott SF, Hodson ME, Barnes PJ. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest. 2000;117:1085-1089. (Pubitemid 30228368)
48. Maniscalco M, Sofia M, Carratu L, Higenbottam T. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest. 2001;31:462-466. (Pubitemid 32476966)
49. Djupesland PG, Chatkin JM, Qian W, et al. Aerodynamic influences on nasal nitric oxide output measurements. Acta Otolaryngol (Stockh). 1999;119:479-485. (Pubitemid 29336456)
50. Cardell LO. The paranasal sinuses and a unique role in airway nitric oxide production? Am J Respir Crit Care Med. 2002;166:131-132. (Pubitemid 34765445)
51. Timperley D, Schlosser R, Harvey R. Chronic rhinosinusitis: an education and treatment model. Otolaryngol Head Neck Surg. 2010;143(suppl 3):S3-S8.
52. Hood CM, Schroter RC, Doorly DJ, Blenke EJSM, Tolley NS. Computational modeling of flow and gas exchange in models of the human maxillary sinus. J Appl Physiol. 2009;107:1195-1203.
53. Brumund KT, Graham SM, Beck KC, Hoffman EA, McLennan G. The effect of maxillary sinus antrostomy size on xenon ventilation in the sheep model. Otolaryngol Head Neck Surg. 2004;131:528-533. (Pubitemid 39298226)
54. Ooi EH, Wormald PJ, Tan LW. Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am J Rhinol. 2008;22:13-19.
55. Rice DH, Schaefer SD. Endoscopic Paranasal Sinus Surgery. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
56. Chu CT, Lebowitz RA, Jacobs JB. An analysis of sites of disease in revision endoscopic sinus surgery. Am J Rhinol. 1997;11:287-291. (Pubitemid 127773056)
57. Browne JP, Hopkins C, Slack R, et al. Health-related quality of life after polypectomy with and without additional surgery. Laryngoscope. 2006;116:297-302. (Pubitemid 44383942)